209 related articles for article (PubMed ID: 21518837)
1. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
[TBL] [Abstract][Full Text] [Related]
3. Linezolid pharmacokinetics in adult patients with cystic fibrosis.
Bosso JA; Flume PA; Gray SL
Antimicrob Agents Chemother; 2004 Jan; 48(1):281-4. PubMed ID: 14693551
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics of linezolid in patients treated in a compassionate-use program.
Meagher AK; Forrest A; Rayner CR; Birmingham MC; Schentag JJ
Antimicrob Agents Chemother; 2003 Feb; 47(2):548-53. PubMed ID: 12543657
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics of linezolid in adults with pulmonary tuberculosis.
McGee B; Dietze R; Hadad DJ; Molino LP; Maciel EL; Boom WH; Palaci M; Johnson JL; Peloquin CA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3981-4. PubMed ID: 19564361
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation.
Kidd JM; Sakon CM; Oleksiuk LM; Cies JJ; Pettit RS; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31685468
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of ciprofloxacin in pediatric cystic fibrosis patients.
Schaefer HG; Stass H; Wedgwood J; Hampel B; Fischer C; Kuhlmann J; Schaad UB
Antimicrob Agents Chemother; 1996 Jan; 40(1):29-34. PubMed ID: 8787874
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients.
Sasaki T; Takane H; Ogawa K; Isagawa S; Hirota T; Higuchi S; Horii T; Otsubo K; Ieiri I
Antimicrob Agents Chemother; 2011 May; 55(5):1867-73. PubMed ID: 21357301
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic research on three different infusion time regimens of linezolid in healthy Chinese volunteers.
Cai Y; Bai N; Liu X; Liang B; Wang J; Wang R
Int J Clin Pharmacol Ther; 2015 Sep; 53(9):765-71. PubMed ID: 26227096
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic evaluation of linezolid in patients with major thermal injuries].
Le Floch R; Arnould JF; Vinsonneau C; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Lovering AM
Pathol Biol (Paris); 2010 Apr; 58(2):e27-31. PubMed ID: 19854590
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
[TBL] [Abstract][Full Text] [Related]
14. Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients.
Plock N; Buerger C; Joukhadar C; Kljucar S; Kloft C
Drug Metab Dispos; 2007 Oct; 35(10):1816-23. PubMed ID: 17639029
[TBL] [Abstract][Full Text] [Related]
15. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
[TBL] [Abstract][Full Text] [Related]
16. Absolute bioavailability and pharmacokinetics of linezolid in hospitalized patients given enteral feedings.
Beringer P; Nguyen M; Hoem N; Louie S; Gill M; Gurevitch M; Wong-Beringer A
Antimicrob Agents Chemother; 2005 Sep; 49(9):3676-81. PubMed ID: 16127039
[TBL] [Abstract][Full Text] [Related]
17. Single dose pharmacokinetics of linezolid in infants and children.
Kearns GL; Abdel-Rahman SM; Blumer JL; Reed MD; James LP; Jacobs RF; Bradley JA; Welshman IR; Jungbluth GL; Stalker DJ;
Pediatr Infect Dis J; 2000 Dec; 19(12):1178-84. PubMed ID: 11144380
[TBL] [Abstract][Full Text] [Related]
18. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic comparison of linezolid, teicoplanin and vancomycin against clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci collected from hospitals in Brazil.
Kuti JL; Kiffer CR; Mendes CM; Nicolau DP
Clin Microbiol Infect; 2008 Feb; 14(2):116-23. PubMed ID: 18076672
[TBL] [Abstract][Full Text] [Related]
20. Intrapulmonary pharmacokinetics of linezolid.
Conte JE; Golden JA; Kipps J; Zurlinden E
Antimicrob Agents Chemother; 2002 May; 46(5):1475-80. PubMed ID: 11959585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
